Recently developed custom acquisition protocols for collection of clinically-defines human specimens.
Obtaining frozen and viable cellular sub-fractions from blood and bone marrow (haematological malignancies).
Procurement of matching specimen sets from patients with solid tumours (tumour and adjacent normal tissues, serum/plasma, viable PBMCs, RNA, DNA, ect.).
Development of primary cell lines from solid tumours and normal tissues.
Collection of frozen and FFPE tumour specimens with follow-up date (colorectal cancer, breast cancer, glioblastoma, ect.).
Procurement of specimen sets (tissue biopsy, synovial fluid, PBMCs, serum, ect.) from patients with inflammatory diseases (rheumatoid arthritis, lupus, asthma, ect.).
Post-mortem collection of disease-targeted tissues from donors with neurological diseases (Parkinson’s disease, Alzheimer’s disease, and others).
Procurement of normal tissue sets for cross-reactivity testing.